


Healthcare News Roundup: Oncology
HSMN NewsFeed - 1 Aug 2018
Oncorus(R), Inc., Names Industry Veteran Ted Ashburn as new President and CEO
Oncorus(R), Inc., Names Industry Veteran Ted Ashburn as new President and CEO
HSMN NewsFeed - 31 Jul 2018
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience
HSMN NewsFeed - 30 Jul 2018
ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer
ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer
HSMN NewsFeed - 30 Jul 2018
Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate
Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate
HSMN NewsFeed - 27 Jul 2018
Accord Healthcare’s (Intas) Pelgraz(R) (pegfilgrastim) Given Green Light by CHMP
Accord Healthcare’s (Intas) Pelgraz(R) (pegfilgrastim) Given Green Light by CHMP
HSMN NewsFeed - 27 Jul 2018
Elekta Digital Strategy Strengthened Through Acquisition of Quality Assurance Expert Acumyn
Elekta Digital Strategy Strengthened Through Acquisition of Quality Assurance Expert Acumyn
HSMN NewsFeed - 26 Jul 2018
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE(R) Technology
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE(R) Technology
HSMN NewsFeed - 25 Jul 2018
Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact(R) System
Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact(R) System
HSMN NewsFeed - 24 Jul 2018
Sutro Biopharma Collaborates with Merck to Develop Therapeutics for Cancer and Autoimmune Disorders
Sutro Biopharma Collaborates with Merck to Develop Therapeutics for Cancer and Autoimmune Disorders
HSMN NewsFeed - 17 Jul 2018
Qfix Releases New Product to Improve Brachytherapy Workflows and Patient Transport
Qfix Releases New Product to Improve Brachytherapy Workflows and Patient Transport
HSMN NewsFeed - 11 Jul 2018
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
HSMN NewsFeed - 9 Jul 2018
Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board
Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board
HSMN NewsFeed - 6 Jul 2018
ITUS Corporation Announces Second Commercial Focus for Cchek(TM) will be Breast Cancer
ITUS Corporation Announces Second Commercial Focus for Cchek(TM) will be Breast Cancer
HSMN NewsFeed - 28 Jun 2018
Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
HSMN NewsFeed - 25 Jun 2018
Radiation oncologists urge Congress to protect patient access to cancer care
Radiation oncologists urge Congress to protect patient access to cancer care
HSMN NewsFeed - 21 Jun 2018
AdoRx Therapeutics Announces Initial Funding of $10 Million for the Discovery of New Cancer Therapeutics
AdoRx Therapeutics Announces Initial Funding of $10 Million for the Discovery of New Cancer Therapeutics
HSMN NewsFeed - 21 Jun 2018
Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India
Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India
HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
HSMN NewsFeed - 18 Jun 2018
Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study
Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study
HSMN NewsFeed - 15 Jun 2018
MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress
MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress
HSMN NewsFeed - 12 Jun 2018
Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
